Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A
Clinical trial NCT06579144 · COMPLETED
Trial details
- NCT number
- NCT06579144
- Sponsor
- Swedish Orphan Biovitrum
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-24
- Primary completion
- 2026-05-21
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.